Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ebselen add-on for acute mania or hypomania in bipolar disorder
2015-000323-86Phase 2Unknown
- Sponsor
- University of Oxford
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar disorder (BD), mania and hypomania comparing Ebselen add-on with Placebo add-on (2 arms). Primary endpoint: Change in Young Mania Rating Scale. Status: unknown.
02
Drugs
ebselen
03
Conditions
bipolar disorder (BD)maniahypomania
Beyond the preview
Go deeper on 2015-000323-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000323-86.